The recent marketing granted orders the US Food and Drug Administration issued for Juul and, earlier, for Vuse Alto show there are multiple ways to get through the premarket tobacco product application pathway. Essentially, Juul succeeded by accentuating the positive, while Vuse’s owner, RJ Reynolds Vapor Company, minimised the negative.
We analyse the FDA justification given in the Juul and Vuse Alto MGOs to see the type of evidence a company needs to provide to demonstrate its product can provide an overall net gain in public health.
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the ECigIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.
Our Key Benefits
The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Curious to see ECigIntelligence in action?
Submit your access request to explore how it streamlines access to critical market and regulatory insights
